The Endocrine System from Our Neurotransmitter Chapter: Endocrine Neurotransmitters Convey a Message from the Glands Secrete Sending Neuron to the Receiving Neuron(S)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Expression Pattern of Delta-Like 1 Homolog in Developing Sympathetic Neurons and Chromaffin Cells
Published in "Gene Expression Patterns 30: 49–54, 2018" which should be cited to refer to this work. Expression pattern of delta-like 1 homolog in developing sympathetic neurons and chromaffin cells ∗ Tehani El Faitwria,b, Katrin Hubera,c, a Institute of Anatomy & Cell Biology, Albert-Ludwigs-University Freiburg, Albert-Str. 17, 79104, Freiburg, Germany b Department of Histology and Anatomy, Faculty of Medicine, Benghazi University, Benghazi, Libya c Department of Medicine, University of Fribourg, Route Albert-Gockel 1, 1700, Fribourg, Switzerland ABSTRACT Keywords: Delta-like 1 homolog (DLK1) is a member of the epidermal growth factor (EGF)-like family and an atypical notch Sympathetic neurons ligand that is widely expressed during early mammalian development with putative functions in the regulation Chromaffin cells of cell differentiation and proliferation. During later stages of development, DLK1 is downregulated and becomes DLK1 increasingly restricted to specific cell types, including several types of endocrine cells. DLK1 has been linked to Adrenal gland various tumors and associated with tumor stem cell features. Sympathoadrenal precursors are neural crest de- Organ of Zuckerkandl rived cells that give rise to either sympathetic neurons of the autonomic nervous system or the endocrine Development ffi Neural crest chroma n cells located in the adrenal medulla or extraadrenal positions. As these cells are the putative cellular Phox2B origin of neuroblastoma, one of the most common malignant tumors in early childhood, their molecular char- acterization is of high clinical importance. In this study we have examined the precise spatiotemporal expression of DLK1 in developing sympathoadrenal cells. We show that DLK1 mRNA is highly expressed in early sympa- thetic neuron progenitors and that its expression depends on the presence of Phox2B. -
Actions of Vasoactive Intestinal Peptide on the Rat Adrenal Zona Glomerulosa
51 Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa J P Hinson, J R Puddefoot and S Kapas1 Molecular and Cellular Biology Section, Division of Biomedical Sciences, St Bartholomew’s and The Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, Mile End Road, London E1 4NS, UK 1Oral Diseases Research Centre, St Bartholomew’s and The Royal London School of Medicine and Dentistry, 2 Newark Street, London E1 2AT, UK (Requests for offprints should be addressed to J P Hinson) Abstract Previous studies, by this group and others, have shown that The response to VIP in adrenals obtained from rats fed vasoactive intestinal peptide (VIP) stimulates aldosterone a low sodium diet was also investigated. Previous studies secretion, and that the actions of VIP on aldosterone have found that adrenals from animals on a low sodium secretion by the rat adrenal cortex are blocked by â diet exhibit increased responsiveness to VIP. Specific VIP adrenergic antagonists, suggesting that VIP may act by binding sites were identified, although the concentration the local release of catecholamines. The present studies or affinity of binding sites in the low sodium group was not were designed to test this hypothesis further, by measur- significantly different from the controls. In the low sodium ing catecholamine release by adrenal capsular tissue in group VIP was found to increase catecholamine release to response to VIP stimulation. the same extent as in the control group, however, in Using intact capsular tissue it was found that VIP caused contrast to the control group, the adrenal response to VIP a dose-dependent increase in aldosterone secretion, with a was not altered by adrenergic antagonists in the low concomitant increase in both adrenaline and noradrenaline sodium group. -
Affect Breast Cancer Risk
HOW HORMONES AFFECT BREAST CANCER RISK Hormones are chemicals made by the body that control how cells and organs work. Estrogen is a female hormone made mainly in the ovaries. It’s important for sexual development and other body functions. From your first monthly period until menopause, estrogen stimulates normal breast cells. A higher lifetime exposure to estrogen may increase breast cancer risk. For example, your risk increases if you start your period at a young age or go through menopause at a later age. Other hormone-related risks are described below. Menopausal hormone therapy Pills Menopausal hormone therapy (MHT) is The U.S. Food and Drug Administration also known as postmenopausal hormone (FDA) recommends women use the lowest therapy and hormone replacement dose that eases symptoms for the shortest therapy. Many women use MHT pills to time needed. relieve hot flashes and other menopausal Any woman currently taking or thinking symptoms. MHT should be used at the Birth control about taking MHT pills should talk with her lowest dose and for the shortest time pills (oral doctor about the risks and benefits. contraceptives) needed to ease menopausal symptoms. Long-term use can increase breast cancer Vaginal creams, suppositories Current or recent use risk and other serious health conditions. and rings of birth control pills There are 2 main types of MHT pills: slightly increases breast Vaginal forms of MHT do not appear to cancer risk. However, estrogen plus progestin and estrogen increase the risk of breast cancer. However, this risk is quite small alone. if you’ve been diagnosed with breast cancer, vaginal estrogen rings and suppositories are because the risk of Estrogen plus progestin MHT breast cancer for most better than vaginal estrogen creams. -
The Morphology, Androgenic Function, Hyperplasia, and Tumors of the Human Ovarian Hilus Cells * William H
THE MORPHOLOGY, ANDROGENIC FUNCTION, HYPERPLASIA, AND TUMORS OF THE HUMAN OVARIAN HILUS CELLS * WILLIAM H. STERNBERG, M.D. (From the Department of Pathology, School of Medicine, Tulane University of Louisiana and the Charity Hospital of Louisiana, New Orleans, La.) The hilus of the human ovary contains nests of cells morphologically identical with testicular Leydig cells, and which, in all probability, pro- duce androgens. Multiple sections through the ovarian hilus and meso- varium will reveal these small nests microscopically in at least 8o per cent of adult ovaries; probably in all adult ovaries if sufficient sections are made. Although they had been noted previously by a number of authors (Aichel,l Bucura,2 and von Winiwarter 3"4) who failed to recog- nize their significance, Berger,5-9 in 1922 and in subsequent years, pre- sented the first sound morphologic studies of the ovarian hilus cells. Nevertheless, there is comparatively little reference to these cells in the American medical literature, and they are not mentioned in stand- ard textbooks of histology, gynecologic pathology, nor in monographs on ovarian tumors (with the exception of Selye's recent "Atlas of Ovarian Tumors"10). The hilus cells are found in clusters along the length of the ovarian hilus and in the adjacent mesovarium. They are, almost without excep- tion, found in contiguity with the nonmyelinated nerves of the hilus, often in intimate relationship to the abundant vascular and lymphatic spaces in this area. Cytologically, a point for point correspondence with the testicular Leydig cells can be established in terms of nuclear and cyto- plasmic detail, lipids, lipochrome pigment, and crystalloids of Reinke. -
HORMONES and SPORT Insulin, Growth Hormone and Sport
13 HORMONES AND SPORT Insulin, growth hormone and sport P H Sonksen Guy’s, King’s and St Thomas’ School of Medicine, St Thomas’ Hospital, London SE1 7EH, UK; Email: [email protected] Abstract This review examines some interesting ‘new’ histories of blood rather than urine samples. The first method has a insulin and reviews our current understanding of its window of opportunity lasting about 24 h after an injec- physiological actions and synergy with GH in the regu- tion and is most suitable for ‘out of competition’ testing. lation of metabolism and body composition. It reviews the The second method has reasonable sensitivity for as long as history of GH abuse that antedates by many years the 2 weeks after the last injection of GH and is uninfluenced awareness of endocrinologists to its potent anabolic actions. by extreme exercise and suitable for post-competition Promising methods for detection of GH abuse have been samples. This method has a greater sensitivity in men than developed but have yet to be sufficiently well validated to in women. The specificity of both methods seems accept- be ready for introduction into competitive sport. So far, ably high but lawyers need to decide what level of there are two promising avenues for detecting GH abuse. scientific probability is needed to obtain a conviction. Both The first uses immunoassays that can distinguish the methods need further validation before implementation. isomers of pituitary-derived GH from the monomer of Research work carried out as part of the fight against recombinant human GH. The second works through doping in sport has opened up a new and exciting area of demonstrating circulating concentrations of one or more endocrinology. -
Thyroid Hormones in Fetal Growth and Prepartum Maturation
A J FORHEAD and A L FOWDEN Thyroid hormones and fetal 221:3 R87–R103 Review development Thyroid hormones in fetal growth and prepartum maturation A J Forhead1,2 and A L Fowden1 Correspondence should be addressed 1Department of Physiology, Development and Neuroscience, University of Cambridge, Physiology Building, to A L Fowden Downing Street, Cambridge CB2 3EG, UK Email 2Department of Biological and Medical Sciences, Oxford Brookes University, Oxford OX3 0BP, UK [email protected] Abstract The thyroid hormones, thyroxine (T4) and triiodothyronine (T3), are essential for normal Key Words growth and development of the fetus. Their bioavailability in utero depends on " thyroid hormones development of the fetal hypothalamic–pituitary–thyroid gland axis and the abundance " intrauterine growth of thyroid hormone transporters and deiodinases that influence tissue levels of bioactive " maturation hormone. Fetal T4 and T3 concentrations are also affected by gestational age, nutritional and " neonatal adaptation endocrine conditions in utero, and placental permeability to maternal thyroid hormones, which varies among species with placental morphology. Thyroid hormones are required for the general accretion of fetal mass and to trigger discrete developmental events in the fetal brain and somatic tissues from early in gestation. They also promote terminal differentiation of fetal tissues closer to term and are important in mediating the prepartum maturational effects of the glucocorticoids that ensure neonatal viability. Thyroid hormones act directly through anabolic effects on fetal metabolism and the stimulation of fetal oxygen Journal of Endocrinology consumption. They also act indirectly by controlling the bioavailability and effectiveness of other hormones and growth factors that influence fetal development such as the catecholamines and insulin-like growth factors (IGFs). -
Recent Advances in Vasoactive Intestinal Peptide Physiology And
F1000Research 2019, 8(F1000 Faculty Rev):1629 Last updated: 28 NOV 2019 REVIEW Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system [version 1; peer review: 4 approved] Mari Iwasaki1, Yasutada Akiba 1,2, Jonathan D Kaunitz 1,3 1Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA 2Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 3Departments of Medicine and Surgery, UCLA School of Medicine, Los Angeles, CA, USA First published: 12 Sep 2019, 8(F1000 Faculty Rev):1629 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.18039.1) Latest published: 12 Sep 2019, 8(F1000 Faculty Rev):1629 ( https://doi.org/10.12688/f1000research.18039.1) Reviewer Status Abstract Invited Reviewers Vasoactive intestinal peptide (VIP), a gut peptide hormone originally 1 2 3 4 reported as a vasodilator in 1970, has multiple physiological and pathological effects on development, growth, and the control of neuronal, version 1 epithelial, and endocrine cell functions that in turn regulate ion secretion, published nutrient absorption, gut motility, glycemic control, carcinogenesis, immune 12 Sep 2019 responses, and circadian rhythms. Genetic ablation of this peptide and its receptors in mice also provides new insights into the contribution of VIP towards physiological signaling and the pathogenesis of related diseases. F1000 Faculty Reviews are written by members of Here, we discuss the impact of VIP on gastrointestinal function and the prestigious F1000 Faculty. They are diseases based on recent findings, also providing insight into its possible commissioned and are peer reviewed before therapeutic application to diabetes, autoimmune diseases and cancer. -
Diabetes Is a Disease in Which the Body's Ability to Produce Or Respond
Early Signs and Symptoms of diabetes: Early symptoms of diabetes, especially type 2 diabetes, can be subtle or seemingly harmless. Over time, however, you may Diabetes is a disease in which the develop diabetes complications, even if you body’s ability to produce or respond to haven't had diabetes symptoms. In the the hormone insulin is impaired, United States alone, more than 8 million resulting in abnormal metabolism of people have undiagnosed diabetes, Treatments: carbohydrates and elevated levels of according to the American Diabetes Association. Understanding possible glucose (sugar) in the blood. • Insulin therapy diabetes symptoms can lead to early • Oral medications diagnosis and treatment and a lifetime of Diabetes can be broken down into • better health. If you're experiencing any of Diet changes two types, Type 1 and Type 2. Type 1 • Exercise diabetes involves the the following diabetes signs and symptoms, see your doctor. body attacking itself by The medications you take vary by mistake, this then the type of diabetes and how well the causes the body to stop making insulin. With medicine controls you blood glucose levels. Type 2 diabetes the Type 1 diabetics must have insulin. Type 2 body does not respond may or may not include insulin and may just like it should to the be controlled with diet and exercise alone. insulin the pancreas is If you notice any of these changes notify making. Your body tells the pancreas that it needs to make more insulin since the your health care provider. The earlier • insulin that is already there is not working. -
PROGESTERONE? PO Box12004 Like Estrogen, Which Gets Much More Public Attention, Progesterone Is a Female Sex Hormone
FOLD FOLD FOLD DO NOT PRINT DO NOT PRINT DO NOT PRINT Overland Park,KS66282 WHAT IS PROGESTERONE? PO Box12004 Like estrogen, which gets much more public attention, progesterone is a female sex hormone. Women produce it in the ovaries and adrenal glands, and during pregnancy in the placenta. With all the talk about estrogen, progesterone is sometimes left behind as the forgotten female hormone. UNDERSTANDING WHAT ARE HORMONES AND HOW DO THEY WORK? IS PROGESTIN THE SAME THING AS PROGESTERONE? Hormones are our bodies’ chemical messengers. PROGESTERONE They travel through the bloodstream to trigger certain No. Although these terms are often used interchangeably, activities or changes in the body. Hormones work by they do not mean the same thing. Progesterone refers binding to specialized areas of cells known as receptor to the hormone produced in the body, or produced sites. There they initiate a chain of events in specific from a plant source but still chemically identical to cells or organs. For example, progesterone has been human progesterone. In contrast, progestin is a known to initiate a calming effect in the brain, hormone that is synthetically produced and may differ reducing anxiety. in structure to progesterone. You may also have heard of progestogens. This is a general term that applies WHAT DOES PROGESTERONE DO? to the category of both natural and synthetic hormones that act like progesterone in the uterus. See the During the reproductive years, progesterone prepares difference in the molecular structure depicted below. the uterine lining (or womb) for pregnancy. Each month, progesterone levels rise following ovulation. -
Some Fundamentals of Gonadal Development and Function Richmond W
Henry Ford Hospital Medical Journal Volume 8 | Number 3 Article 8 9-1960 Some Fundamentals Of Gonadal Development And Function Richmond W. Smith Jr. Raymond C. Mellinger Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Smith, Richmond W. Jr. and Mellinger, Raymond C. (1960) "Some Fundamentals Of Gonadal Development And Function," Henry Ford Hospital Medical Bulletin : Vol. 8 : No. 3 , 324-344. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol8/iss3/8 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact [email protected]. SOME FUNDAMENTALS OF GONADAL DEVELOPMENT AND FUNCTION* RICHMOND W. SMITH, JR., M.D.** AND RAYMOND C. MELLINGER, M.D.** The traditional division of animal life into male and female forms is based on obvious biological differences, but these distinctions become less striking when we realize that life, in a sheer physico-chemical sense, is a spectrum of sexuality that maleness and femaleness are relative terms. Our conceptual devotion to a two compartment universe is apparent in many areas of life, sociologic, moral, legal, spiritual or biologic. Although reproductive obligations remain clear, albeit increasingly restricted, man's greater social sophistication is molding an order in which underlying biological distinctions of the two sexes are sometimes obscured by the potent solvents of culture, leisure and intellect. -
Chapter 45-Hormones and the Endocrine System Pathway Example – Simple Hormone Pathways Stimulus Low Ph in Duodenum
Chapter 45-Hormones and the Endocrine System Pathway Example – Simple Hormone Pathways Stimulus Low pH in duodenum •Hormones are released from an endocrine cell, S cells of duodenum travel through the bloodstream, and interact with secrete secretin ( ) Endocrine the receptor or a target cell to cause a physiological cell response Blood vessel A negative feedback loop Target Pancreas cells Response Bicarbonate release Insulin and Glucagon: Control of Blood Glucose Body cells •Insulin and glucagon are take up more Insulin antagonistic hormones that help glucose. maintain glucose homeostasis Beta cells of pancreas release insulin into the blood. The pancreas has clusters of endocrine cells called Liver takes islets of Langerhans up glucose and stores it as glycogen. STIMULUS: Blood glucose Blood glucose level level declines. rises. Target Tissues for Insulin and Glucagon Homeostasis: Blood glucose level Insulin reduces blood glucose levels by: (about 90 mg/100 mL) Promoting the cellular uptake of glucose Blood glucose STIMULUS: Slowing glycogen breakdown in the liver level rises. Blood glucose level falls. Promoting fat storage Alpha cells of pancreas release glucagon. Liver breaks down glycogen and releases glucose. Glucagon Glucagon increases blood glucose levels by: Stimulating conversion of glycogen to glucose in the liver Stimulating breakdown of fat and protein into glucose Diabetes Mellitus Type I diabetes mellitus (insulin-dependent) is an autoimmune disorder in which the immune system destroys pancreatic beta cells Type II diabetes -
Downloaded from Bioscientifica.Com at 09/30/2021 12:01:31AM Via Free Access 706 D BARON and Others · Foxl2 and Rainbow Trout Gonad Differentiation
705 An evolutionary and functional analysis of FoxL2 in rainbow trout gonad differentiation Daniel Baron1, Julie Cocquet2, Xuhua Xia3, Marc Fellous2, Yann Guiguen1 and Reiner A Veitia2 1INRA-SCRIBE, Campus de Beaulieu, 35042 Rennes Cedex, France 2INSERM E0021 & V361, Génomique fonctionnelle du Développement, Hôpital Cochin, 123 Bd de Port Royal, Paris, France 3Department of Biology and the Center for Advanced Research in Environmental Genomics, University of Ottawa, Ottawa, Ontario, Canada (Requests for offprints should be addressed to R A Veitia; Email: [email protected]) Abstract FOXL2 is a forkhead transcription factor involved in ovarian development and function. Here, we have studied the evolution and pattern of expression of the FOXL2 gene and its paralogs in fish. We found well conserved FoxL2 sequences (FoxL2a) and divergent genes, whose forkhead domains belonged to the class L2 and were shown to be paralogs of the FoxL2a sequences (named FoxL2b). In the rainbow trout, FoxL2a and FoxL2b were specifically expressed in the ovary, but displayed different temporal patterns of expression. FoxL2a expression correlated with the level of aromatase, the key enzyme in estrogen production, and an estrogen treatment used to feminize genetically male individuals elicited the up-regulation of both paralogs. Conversely, androgens or an aromatase inhibitor down-regulated FoxL2a and FoxL2b in females. We speculate that there is a direct link between estrogens and FoxL2 expression in fish, at least during the period where the identity of the gonad is sensitive to hormonal treatments. Journal of Molecular Endocrinology (2004) 33, 705–715 Introduction been detected (Cocquet et al. 2002, Pannetier et al.